Taipei Exchange - Delayed Quote TWD

Taiwan Advance Bio-Pharmaceutical Inc. (4186.TWO)

Compare
15.75
-0.15
(-0.94%)
At close: 1:15:07 PM GMT+8

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.
NameTitlePayExercisedYear Born
Mr. Ji-Hong Huang Deputy Managing Director -- -- --

Taiwan Advance Bio-Pharmaceutical Inc.

No. 25, Kangning Street
12 Floor Lane 169 Xizhi District
New Taipei City, 22180
Taiwan
886 2 2692 6222 https://www.biotest.com.tw
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
154

Description

Taiwan Advance Bio-Pharmaceutical Inc. operates in the biotechnology industry in China Germany, USA, Italy, Malaysia, Vietnam, Thailand, Indonesia, Japan, Korea, India, Pakistan, and internationally. The company provides food safety diagnostic testing kits; ELISA, rapid, and chemical test kits customization, and food safety lab establishment consultation services; and manufactures monoclonal and polyclonal antibody products. It also offers abused drugs rapid tests; provides cell banking services for newborn and adult stem cells storage; and operates drug testing center for urine drug test, hair drug test, and identification of drug abuse. The company was founded in 1989 and is based in New Taipei City, Taiwan.

Corporate Governance

Taiwan Advance Bio-Pharmaceutical Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

Related Tickers